Related Articles
Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study
Mismatch repair proteins expression and tumor‑infiltrating T‑cells in colorectal cancer
TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma Corrigendum in /10.3892/or.2022.8411
Challenges in bioinformatics approaches to tumor mutation burden analysis
Comparative analysis of target gene exon sequencing by cognitive technology using a next generation sequencing platform in patients with lung cancer